🚀 VC round data is live in beta, check it out!
Cannabis Poland Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cannabis Poland and similar public comparables like Double Bond, JFL Life Sciences, Geovax Labs, HCW Biologics and more.
Cannabis Poland Overview
About Cannabis Poland
Cannabis Poland SA is engaged in the business of cannabis, wherein it supplies plant products containing cannabinoids for pharmaceutical industry.
Founded
2012
HQ
Employees
3
Website
Sectors
Financials (FY)
EV
$3M
Cannabis Poland Financials
Cannabis Poland reported last fiscal year revenue of $59K and negative EBITDA of ($611K).
In the same fiscal year, Cannabis Poland generated $21K in gross profit, ($611K) in EBITDA losses, and had net loss of ($541K).
Cannabis Poland P&L
In the most recent fiscal year, Cannabis Poland reported revenue of $59K and EBITDA of ($611K).
Cannabis Poland expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $59K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $21K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 35% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($611K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (1038%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (1136%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($541K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (920%) | XXX | XXX | XXX |
| Net Debt | — | — | $120K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cannabis Poland Stock Performance
Cannabis Poland has current market cap of $3M, and enterprise value of $3M.
Market Cap Evolution
Cannabis Poland's stock price is $0.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3M | $3M | 0.1% | XXX | XXX | XXX | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCannabis Poland Valuation Multiples
Cannabis Poland trades at 49.6x EV/Revenue multiple, and (4.8x) EV/EBITDA.
Cannabis Poland Financial Valuation Multiples
As of April 19, 2026, Cannabis Poland has market cap of $3M and EV of $3M.
Equity research analysts estimate Cannabis Poland's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cannabis Poland has a P/E ratio of (6.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3M | XXX | $3M | XXX | XXX | XXX |
| EV (current) | $3M | XXX | $3M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 49.6x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (4.8x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (4.4x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 141.1x | XXX | XXX | XXX |
| P/E | — | XXX | (6.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (4.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cannabis Poland Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cannabis Poland Margins & Growth Rates
Cannabis Poland's revenue in the last fiscal year declined by (16%).
Cannabis Poland's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.
Cannabis Poland Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (16%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (1038%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 1% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 1171% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cannabis Poland Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Cannabis Poland | XXX | XXX | XXX | XXX | XXX | XXX |
| Double Bond | XXX | XXX | XXX | XXX | XXX | XXX |
| JFL Life Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Geovax Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| HCW Biologics | XXX | XXX | XXX | XXX | XXX | XXX |
| CASI Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cannabis Poland M&A Activity
Cannabis Poland acquired XXX companies to date.
Last acquisition by Cannabis Poland was on XXXXXXXX, XXXXX. Cannabis Poland acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cannabis Poland
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCannabis Poland Investment Activity
Cannabis Poland invested in XXX companies to date.
Cannabis Poland made its latest investment on XXXXXXXX, XXXXX. Cannabis Poland invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cannabis Poland
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cannabis Poland
| When was Cannabis Poland founded? | Cannabis Poland was founded in 2012. |
| Where is Cannabis Poland headquartered? | Cannabis Poland is headquartered in Poland. |
| How many employees does Cannabis Poland have? | As of today, Cannabis Poland has over 3 employees. |
| Is Cannabis Poland publicly listed? | Yes, Cannabis Poland is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Cannabis Poland? | Cannabis Poland trades under CBD ticker. |
| When did Cannabis Poland go public? | Cannabis Poland went public in 2013. |
| Who are competitors of Cannabis Poland? | Cannabis Poland main competitors are Double Bond, JFL Life Sciences, Geovax Labs, HCW Biologics. |
| What is the current market cap of Cannabis Poland? | Cannabis Poland's current market cap is $3M. |
| What is the current revenue of Cannabis Poland? | Cannabis Poland's last fiscal year revenue is $59K. |
| What is the current EV/Revenue multiple of Cannabis Poland? | Current revenue multiple of Cannabis Poland is 49.6x. |
| Is Cannabis Poland profitable? | No, Cannabis Poland is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.